OCTN cation transporters in health and disease: role as drug targets and assay development.
about
Caveolin-1--a novel interacting partner of organic cation/carnitine transporter (Octn2): effect of protein kinase C on this interaction in rat astrocytesGastrointestinal dysfunction in autism spectrum disorder: the role of the mitochondria and the enteric microbiome.Protein Kinases C-Mediated Regulations of Drug Transporter Activity, Localization and Expression.Drug Transporters and Na+/H+ Exchange Regulatory Factor PSD-95/Drosophila Discs Large/ZO-1 ProteinsOrganic and inorganic transporters of the testis: A review.Dysregulated Homeostasis of Acetylcholine Levels in Immune Cells of RR-Multiple Sclerosis Patients.Wide tolerance to amino acids substitutions in the OCTN1 ergothioneine transporter.Membrane transporters for the special amino acid glutamine: structure/function relationships and relevance to human health.Drug transporters in the nasal epithelium: an overview of strategies in targeted drug delivery.Multiple AMPK activators inhibit l-carnitine uptake in C2C12 skeletal muscle myotubes.Story behind meldonium-from pharmacology to performance enhancement: a narrative review.Inflammatory Bowel Disease: Updates on Molecular Targets for Biologics.Carnitine transport and fatty acid oxidation.Functional and molecular effects of mercury compounds on the human OCTN1 cation transporter: C50 and C136 are the targets for potent inhibition.Proteoliposomes as tool for assaying membrane transporter functions and interactions with xenobiotics.Dual targeting of l-carnitine-conjugated nanoparticles to OCTN2 and ATB0,+ to deliver chemotherapeutic agents for colon cancer therapy.Protein phosphatase PP2A - a novel interacting partner of carnitine transporter OCTN2 (SLC22A5) in rat astrocytes.Transporter-Guided Delivery of Nanoparticles to Improve Drug Permeation across Cellular Barriers and Drug Exposure to Selective Cell Types.Identification of key genes and pathways in human clear cell renal cell carcinoma (ccRCC) by co-expression analysis.Characterization of Exosomal SLC22A5 (OCTN2) carnitine transporter.New Water-Soluble Carbamate Ester Derivatives of Resveratrol
P2860
Q28537671-C8C12D2D-310D-4B7E-8B66-8E1EF2F65D5BQ30410996-D8351DF3-86B0-483B-ADCC-B6CDC97DF65DQ33624522-DB3F0D11-1204-4D2F-9188-346FA89AC4A8Q35795744-006B2BBF-F31C-4B28-803E-06A8B2F56056Q36088091-3DDA16E9-AF90-45F1-A383-3DE5932A01ADQ36213007-174B48E8-22BD-4732-AF44-1695F88A4E31Q36817792-D308FD91-3D1A-4AE2-8E1E-9C412DE5C13EQ38243334-775EB584-E34F-4870-90FA-5DE31CC8A67AQ38261366-09100B89-DCEF-487A-863F-64689513FDB6Q38712159-8BD1D300-AAFA-4464-8D70-6B2C1DCDCD5CQ38910604-8EC69A0F-CB22-4EF2-A9FD-B4837CCE677AQ39293951-8F18C4E8-C388-440B-9F82-F92761E3FBF4Q41633875-4FD0054E-FAAB-4316-B753-862D65EB33AEQ41710987-5765514A-FF7F-4306-BBCC-5B83CD2745FCQ42873690-F1450A5C-929B-46EE-9AC7-02EE7DB6E0AEQ47801001-D847E69A-352C-4E82-8090-7FBE8758F9A8Q48564025-BBE04A5D-262C-4064-929E-6981F2E32DFCQ49472868-EC304B68-D675-45FC-906F-78A28D06635EQ51737515-BDC07E5D-F6D8-435F-A540-978580B49B32Q52680667-74DF04AA-EA52-4350-8CC5-9AF66D850A9EQ57974104-6A60F176-8443-4882-95EF-4B2D0E3C9DE4
P2860
OCTN cation transporters in health and disease: role as drug targets and assay development.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
OCTN cation transporters in he ...... targets and assay development.
@en
type
label
OCTN cation transporters in he ...... targets and assay development.
@en
prefLabel
OCTN cation transporters in he ...... targets and assay development.
@en
P2093
P2860
P356
P1476
OCTN cation transporters in he ...... targets and assay development.
@en
P2093
Cesare Indiveri
Lorena Pochini
Mariafrancesca Scalise
Michele Galluccio
P2860
P304
P356
10.1177/1087057113493006
P577
2013-06-14T00:00:00Z